Table 3.
Baseline | 3rd month | |||
---|---|---|---|---|
Resveratrol (EI) | Placebo (EI) | Resveratrol (EI) | Placebo (EI) | |
Shear stress | ||||
30 (Pa) | 0.619 ± 0.003 | 0.623 ± 0.001 | 0.621 ± 0.002 | 0.623 ± 0.001 |
3 (Pa) | 0.415 ± 0.004 | 0.420 ± 0.003 | 0.414 ± 0.004 | 0.422 ± 0.003 |
0.3 (Pa) | 0.008 ± 0.009 | 0.009 ± 0.006 | 0.005 ± 0.007 | 0.009 ± 0.006 |
Values are expressed as mean ± SEM. There was no difference in the EI values at any shear stresses between the placebo, resveratrol baseline, and 3rd month groups. Baseline: measured values at randomization in the resveratrol or placebo group; 3rd month: patients treated with resveratrol or placebo for 3 months. EI: elongation index; Pa: pascal.